| RS1571123333 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1571134523 |
ATF6
|
Health Risk |
Pathogenic |
Achromatopsia 7, Retinal dystrophy |
| RS1571138735 |
PEX19
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS1571143590 |
ATF6
|
Health Risk |
Pathogenic |
Achromatopsia 7, Achromatopsia 7 |
| RS1571147567 |
LMX1A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 7 |
| RS1571150562 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial dilated cardiomyopathy, Hypertrophic cardiomyopathy 20 |
| RS1571153052 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS1571155763 |
TBX15
|
Health Risk |
Likely pathogenic |
— |
| RS1571158279 |
RPE65
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 87 with choroidal involvement, Retinal dystrophy |
| RS1571158755 |
RPE65
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1571164162 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS1571164333 |
RPE65
|
Health Risk |
Pathogenic |
Autism, Global developmental delay |
| RS1571164534 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1571165140 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1571170561 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 20 |
| RS1571172233 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1571175899 |
GJA8
|
Health Risk |
Likely pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1571175950 |
GJA8
|
Health Risk |
Pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1571177726 |
LMX1A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 7 |
| RS1571202126 |
NCSTN
|
Health Risk |
Likely pathogenic |
— |
| RS1571217834 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1571229515 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1571231587 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1571232214 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1571232325 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1571232404 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1571232632 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, See cases |
| RS1571232872 |
GORAB-AS1;GORAB
|
Health Risk |
Likely pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS1571234939 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS1571235473 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1571236369 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1571237925 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS1571238473 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1571238944 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1571239957 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1571240391 |
AHDC1
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1571241930 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Retinal dystrophy |
| RS1571241947 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Retinal dystrophy |
| RS1571242070 |
ABCA4
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy, Age related macular degeneration 2 |
| RS1571242220 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1571242436 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1571243037 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1571243699 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1571243797 |
GORAB
|
Health Risk |
Pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS1571243862 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1571244033 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1571245809 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1571247308 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1571250020 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1571250077 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1571252997 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1571253050 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571256140 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency 3, MHC class II deficiency 3 |
| RS1571256775 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1571257754 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Cone-rod dystrophy 3 |
| RS1571257937 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, ABCA4-related retinopathy |
| RS1571257969 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1571258380 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1571258440 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1571259311 |
XPR1
|
Health Risk |
Likely pathogenic |
— |
| RS1571259807 |
KCNN3
|
Health Risk |
Pathogenic |
Zimmermann-Laband syndrome 3, Zimmermann-Laband syndrome 3 |
| RS1571260017 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1571260171 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1571260285 |
KCNN3
|
Health Risk |
Pathogenic |
Zimmermann-Laband syndrome 3, Zimmermann-Laband syndrome 3 |
| RS1571262081 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1571264551 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1571264574 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Age related macular degeneration 2 |
| RS1571265125 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1571265241 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1571265375 |
KCNJ10
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS1571265496 |
KCNJ10
|
Health Risk |
Pathogenic |
SeSAME-like syndrome, SeSAME-like syndrome |
| RS1571266478 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1571285932 |
SLC25A24
|
Health Risk |
Likely pathogenic |
Dementia, Bilateral tonic-clonic seizure |
| RS1571295161 |
DDR2
|
Health Risk |
Likely pathogenic |
— |
| RS1571308125 |
TNR
|
Health Risk |
Pathogenic |
Non-progressive neurodevelopmental disorder with spasticity and transient opisthotonus, Neurodevelopmental disorder |
| RS1571320137 |
IQGAP3
|
Health Risk |
Likely pathogenic |
Motor and sensory neuropathy, Motor and sensory neuropathy |
| RS1571321748 |
POGZ
|
Health Risk |
Likely pathogenic |
Obesity, Obesity |
| RS1571321814 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571323203 |
WARS2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, mitochondrial |
| RS1571323464 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571323536 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571325076 |
DDR2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS1571325144 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS1571326296 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1571326825 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS1571328045 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS1571332089 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1571339601 |
TNR
|
Health Risk |
Pathogenic |
Non-progressive neurodevelopmental disorder with spasticity and transient opisthotonus, Neurodevelopmental disorder |
| RS1571340772 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571342521 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS1571346132 |
CDC14A
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS1571352321 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS1571353663 |
KCNN3
|
Health Risk |
Pathogenic |
Zimmermann-Laband syndrome 3, Zimmermann-Laband syndrome 3 |
| RS1571354325 |
PRRX1
|
Health Risk |
Pathogenic |
Agnathia-otocephaly complex, Agnathia-otocephaly complex |
| RS1571356820 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571357779 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, Variegate porphyria |
| RS1571360953 |
TNR
|
Health Risk |
Pathogenic |
Non-progressive neurodevelopmental disorder with spasticity and transient opisthotonus, Neurodevelopmental disorder |
| RS1571369150 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, Variegate porphyria |
| RS1571392612 |
PLA2G4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder, Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder |
| RS1571406458 |
PPOX
|
Health Risk |
Pathogenic |
— |